Your browser doesn't support javascript.
loading
Planning Trade-offs for SABR in Patients With 4 to 10 Metastases: A Substudy of the SABR-COMET-10 Randomized Trial.
Ashram, Samaher; Bahig, Houda; Barry, Aisling; Blanchette, Denise; Celinksi, Anders; Chung, Peter; Darko, Johnson; Donath, David; Doucet, Robert; Erickson, Abigail; Giuliani, Meredith; Gopaul, Darin; Hipwell, Scott; Javor, Joanna; Kuk, Joda; Lindsay, Patricia; Millman, Barbara; Oliver, Michael; Pearce, Andrew; Russell, Catherine; Senthi, Sashendra; Vu, Toni; Warner, Andrew; Gaede, Stewart; Palma, David A.
Afiliação
  • Ashram S; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada.
  • Bahig H; Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada.
  • Barry A; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Blanchette D; Northeast Cancer Centre, Sudbury, Ontario, Canada.
  • Celinksi A; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada.
  • Chung P; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Darko J; Grand River Cancer Centre, Kitchener, Ontario, Canada.
  • Donath D; Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada.
  • Doucet R; Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada.
  • Erickson A; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada.
  • Giuliani M; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Gopaul D; Grand River Cancer Centre, Kitchener, Ontario, Canada.
  • Hipwell S; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada.
  • Javor J; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Kuk J; Grand River Cancer Centre, Kitchener, Ontario, Canada.
  • Lindsay P; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Millman B; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada.
  • Oliver M; Northeast Cancer Centre, Sudbury, Ontario, Canada.
  • Pearce A; Northeast Cancer Centre, Sudbury, Ontario, Canada.
  • Russell C; Alfred Health, Melbourne, Australia.
  • Senthi S; Alfred Health, Melbourne, Australia.
  • Vu T; Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada.
  • Warner A; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada.
  • Gaede S; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada.
  • Palma DA; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada. Electronic address: david.palma@lhsc.on.ca.
Int J Radiat Oncol Biol Phys ; 114(5): 1011-1015, 2022 12 01.
Article em En | MEDLINE | ID: mdl-35667527
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radiocirurgia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radiocirurgia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article